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Abstract
Aims: This paper describes a simple technique of axillary and breast massage which improves the
successful identification of blue sentinel nodes using patent blue dye alone.
Methods: Patent blue dye was injected in the subdermal part of the retroaroelar area in 167
patients having surgical treatment for invasive breast cancer. Three stage axillary lymphatic massage
was performed prior to making the axillary incision for sentinel lymph node biopsy. All patients had
completion axillary sampling or clearance.
Results: A blue lymphatic duct leading to lymph nodes of the first drainage was identified in 163
(97%) of the patients. Results are compared with 168 patients who had sentinel lymph node biopsy
using blue dye without axillary massage. Allergic reactions were observed in four patients (1.2%).
Conclusion: Three stage axillary lymphatic massage improves the successful identification of a
blue sentinel lymph node in breast cancer patients.
Introduction
Lymphatic mapping using blue dye, radiolabelled colloid
or both to identify the sentinel lymph node in breast can-
cer surgery is becoming the standard of care. In the valida-
tion phase of the ALMANAC trial surgeons achieving a
localization rate of = 90% using a combined technique of
blue dye and radioisotope proceeded to the randomiza-
tion phase in which the success rate for localization of the
sentinel lymph node was 98% [1]. A number of studies
(Table 1) have reported a localization rate in the range of
85–98% using the combined technique, [2-4] However
Adwani and Giuliano have reported a 90–95% success
rate of localization of the sentinel node using the blue dye
alone without and with a breast massage respectively
[5,6]. Although both radiocolloid and blue dye are used
together by most surgeons, and training should be in both
techniques, some experienced surgeons use one or the
other almost exclusively. [6,7]
We report a technique using a three stage axillary and
breast massage after subcutaneous injection of 2 ml of
patent blue dye alone. This massage technique applies the
principle of manual lymphatic drainage and is based on
the physiology of lymphatic flow described originally by
Winiwarter (1892) and Vodder (1982). It improves the
localisation of a blue lymphatic duct in the axilla and
almost always leads to successful identification of the blue
sentinel lymph node. [8]
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Methods
We injected 2 ml of 2.5 per cent undiluted patent blue V
sodium dye subdermally in the retroaroelar area at the
upper outer quadrant of the breast. The lymphatic mas-
sage was performed in three stages. In the first stage the
axilla was massaged to empty axillary lymph nodes (Fig.
1). The lymph node massage was performed with the tips
of two or three fingers. These were placed over the nodes,
and pressure was applied like a gentle "scoop" in the
direction of further flow from them. The fingers did not
move over the skin; rather, they applied pressure during
the "scoop" and released it [8]. In the second stage a retro-
grade massage was undertaken from the axilla towards the
injection site. This was performed using the palm of the
hand and fingers using light stroking movements over the
skin. The final step was to massage from the injected area
towards the axilla (Antegrade massage) to drain the blue
dye into lymphatics and axillary lymph nodes (Fig. 2).
The three stage massage takes about one minute to com-
plete. It uses light-pressured strokes in a specific direction
to stimulate the lymph vessels just below the surface of
the skin without increasing blood circulation or reaching
the depth of muscle tissue. It was thought necessary to
allow about seven minutes before making the axillary
incision to provide the blue dye enough time to reach the
axillary glands. All patients had completion axillary sam-
pling or clearance.
Results
In 167 patients with three stage axillary lymphatic mas-
sage a blue sentinel lymph node was identified in 163
patients thereby achieving a localisation rate of 97%. We
compared the results with our previous technique of sim-
ple massage from the injection site towards the axilla
(Antegrade massage). A blue sentinel lymph node had
been identified in 144 of 168 patients with simple ante-
grade massage alone, a localisation rate of only 85%.
Four patients (1.2%) developed allergic reaction to patent
blue dye which manifested in the form of blisters or wheal
and blue hives with bluish discolouration of the skin. One
of these patients became hypotensive. All reactions
occurred within 45 minutes of the injection and were
Stage 2 retrograde and stage 3 antegrade massage Figure 2
Stage 2 retrograde and stage 3 antegrade massage.
First stage of axillary lymphatic massage Figure 1
First stage of axillary lymphatic massage.
Table 1: 
Author Number of Patients Technique Number of SLN* SLN Identification rate (%)
Giuliano 1997 107 Blue Dye Only 1.8 93
Veronesi 2003 649 Radiocolloid only 2.7 98.7
Krag 1998 443 Radiocolloid only 2.5 93
ALMANAC Mansel 2006 1031 Combined Blue Dye and Radiocolloid 2.4 98
Hadjiminas 2005 234 Combined Blue Dye and Radiocolloid 1.38 94.5
Kuehn 2004 1124 Combined Blue Dye and Radiocolloid 2 85
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treated by a single intravenous injection of 200 mg of
Prednisolone.
The false negative rate was 6% in the antegrade massage
group and zero per cent in the three stage axillary lym-
phatic massage group. The new technique also improved
the sensitivity and specificity from 70 and 88 per cent with
simple antegrade massage to 84% and 100% with a three
stage massage.
Discussion
Axillary sentinel lymph node biopsy allows a minimal
invasion of the axillary area in order to obtain a limited
number of axillary lymph nodes to identify patients who
do not have nodal metastases. This avoids a more exten-
sive axillary dissection with its associated complications.
It is important that techniques used to localise the axillary
sentinel lymph node in breast cancer are optimized to
achieve a high identification rate. A combined technique
using Tc-99 isotope and patent blue dye has been shown
to achieve a localisation rate of up to 98% [1,9,10].
Of the various dyes used for sentinel node localization
patent blue dye is currently recommended for sentinel
node biopsy in breast cancer patients in the United King-
dom. When injected subdermally in any area of the breast
it binds to proteins and is absorbed by the lymphatics and
highlights the lymphatic drainage and the sentinel lymph
node in the axilla [11]. Three stage lymphatic massage
works by first emptying the "reservoir" in the lymph
nodes creating an empty space into which lymphatics
containing the blue dye can be emptied easily [8].
A localisation rate of over 90% is currently recommended
to assure quality in breast cancer surgery [7,12,13]. We
report in this study that a localisation rate of 97% is
achievable by using blue dye alone with axillary lym-
phatic massage in three stages. This technique can be use-
ful for breast surgeons working in breast units where
facilities for nuclear medicine are not readily available
[14]. A blue dye assisted four node sampling can be per-
formed making it a targeted axillary sampling [15]. A
comparison of Methylene blue dye and combined dye
and radioactive technique has shown that the blue dye
technique with breast massage can be as accurate as the
combined isotope dye technique [16].
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